Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model. (2025). International Journal of Environmental Sciences, 11(12s), 1360-1367. https://doi.org/10.64252/8crhea08